These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 24873809)

  • 41. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pacing for heart block after septal reduction therapy.
    Okreglicki AM
    Am J Cardiol; 2004 Nov; 94(9):1224. PubMed ID: 15518634
    [No Abstract]   [Full Text] [Related]  

  • 43. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
    ; Elliott PM; Anastasakis A; Borger MA; Borggrefe M; Cecchi F; Charron P; Hagege AA; Lafont A; Limongelli G; Mahrholdt H; McKenna WJ; Mogensen J; Nihoyannopoulos P; Nistri S; Pieper PG; Pieske B; Rapezzi C; Rutten FH; Tillmanns C; Watkins H
    Eur Heart J; 2014 Oct; 35(39):2733-79. PubMed ID: 25173338
    [No Abstract]   [Full Text] [Related]  

  • 44. Evolving indications for permanent pacemakers.
    Bryce M; Spielman SR; Greenspan AM; Kotler MN
    Ann Intern Med; 2001 Jun; 134(12):1130-41. PubMed ID: 11412054
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Almanac 2013: cardiac arrhythmias and pacing.
    Liew R
    Heart; 2013 Oct; 99(19):1398-407. PubMed ID: 23906730
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [European practice guidelines on cardiac pacemakers and cardiac resynchronization therapy. Working Group of the European Society of Cardiology (ESC) on cardiac pacemakers and cardiac resynchronization therapy. Developed in collaboration with the European Heart Rhythm Association].
    Vardas PE; Auricchio A; Blanc JJ; Daubert JC; Drexler H; Ector H; Gasparini M; Linde C; Bello Morgado F; Oto A; Sutton R; Trusz-Gluza M;
    Rev Esp Cardiol; 2007 Dec; 60(12):1272.e1-1272.e51. PubMed ID: 18082093
    [No Abstract]   [Full Text] [Related]  

  • 47. Second Vasovagal Pacemaker Study (VPS II): rationale, design, results, and implications for practice and future clinical trials.
    Sheldon R; Connolly S;
    Card Electrophysiol Rev; 2003 Dec; 7(4):411-5. PubMed ID: 15071266
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New indications for cardiac pacing].
    Ben Halima A; Kachboura S; Fradi I; Bachraoui K; Mokaddem A; Selmi K; Makni H; Boujnah MR
    Tunis Med; 2003 Apr; 81(4):217-25. PubMed ID: 12848002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of arrhythmias in children--unusual features.
    Vetter VL
    Cardiovasc Clin; 1985; 16(1):329-58. PubMed ID: 3915714
    [No Abstract]   [Full Text] [Related]  

  • 50. Updated guidelines for device-based therapy of cardiac rhythm abnormalities.
    Gillinov AM
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1285. PubMed ID: 23140961
    [No Abstract]   [Full Text] [Related]  

  • 51. A novel method of multisite atrial pacing, incorporating Bachmann's bundle area and coronary sinus ostium, for electrical atrial resynchronization in patients with recurrent atrial fibrillation.
    Lewicka-Nowak E; Kutarski A; Dabrowska-Kugacka A; Rucinski P; Zagozdzon P; Raczak G
    Europace; 2007 Sep; 9(9):805-11. PubMed ID: 17670780
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities.
    Epstein AE; Dimarco JP; Ellenbogen KA; Estes NA; Freedman RA; Gettes LS; Gillinov AM; Gregoratos G; Hammill SC; Hayes DL; Hlatky MA; Newby LK; Page RL; Schoenfeld MH; Silka MJ; Stevenson LW; Sweeney MO; ; ; ;
    Heart Rhythm; 2008 Jun; 5(6):e1-62. PubMed ID: 18534360
    [No Abstract]   [Full Text] [Related]  

  • 53. Implications of mechanism of bradycardia on response to pacing in patients with unexplained syncope.
    Sud S; Klein GJ; Skanes AC; Gula LJ; Yee R; Krahn AD
    Europace; 2007 May; 9(5):312-8. PubMed ID: 17376795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physiologic temporary pacing: techniques and indications.
    Littleford PO
    Cardiovasc Clin; 1985; 15(1):231-52. PubMed ID: 3842329
    [No Abstract]   [Full Text] [Related]  

  • 55. All patients with heart failure and intraventricular conduction defect or dyssynchrony should not receive cardiac resynchronization therapy.
    Greenberg B; Mehra MR
    Circulation; 2006 Dec; 114(24):2685-90; discussion 2691. PubMed ID: 17159074
    [No Abstract]   [Full Text] [Related]  

  • 56. [Cardiac resynchronization: past, present and future].
    Daubert JC; Leclercq C; Mabo P
    Bull Acad Natl Med; 2012 Jun; 196(6):1141-56; discussion 1156-8. PubMed ID: 23596861
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac resynchronization therapy. Indications and contraindications.
    Acena M; Regoli F; Auricchio A
    Rev Esp Cardiol (Engl Ed); 2012 Sep; 65(9):843-9. PubMed ID: 22795365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transesophageal atrial pacing can facilitate beta-adrenergic blockade and heart rate control.
    Roth JV
    Anesth Analg; 1999 Oct; 89(4):1070. PubMed ID: 10512304
    [No Abstract]   [Full Text] [Related]  

  • 59. [Indications for implantation of a permanent artificial cardiac pacemaker].
    Grigorov SS; Votchal FB; Kostyleva OV
    Kardiologiia; 1986 Feb; 26(2):110-1. PubMed ID: 3702189
    [No Abstract]   [Full Text] [Related]  

  • 60. Non-classical indications for cardiac resynchronization therapy.
    Beinart R; Michaelidis A; Glikson M
    Hellenic J Cardiol; 2009; 50(3):208-15. PubMed ID: 19465362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.